skip to Main Content

Merck KGaA invests in antibody-drug conjugates

Read the full press release here Merck KGaA plans to spend $65 million to expand a plant near Madison, Wisconsin, that makes cancer-fighting antibody-drug conjugates for drug industry customers. The German firm says it will add a building that will…

Read More

UW Health to resume COVID-19 vaccine trials

Read the full press release here A planned trial of a COVID-19 vaccine is restarting at UW-Health. That drug trial, run by AstraZeneca and Oxford University, was halted last week after a participant in the United Kingdom had an adverse…

Read More
Back To Top